Attached files

file filename
10-K - 10-K - IRONWOOD PHARMACEUTICALS INCa2197484z10-k.htm
EX-3.1 - EXHIBIT 3.1 - IRONWOOD PHARMACEUTICALS INCa2197484zex-3_1.htm
EX-3.2 - EXHIBIT 3.2 - IRONWOOD PHARMACEUTICALS INCa2197484zex-3_2.htm
EX-32.2 - EXHIBIT 32.2 - IRONWOOD PHARMACEUTICALS INCa2197484zex-32_2.htm
EX-32.1 - EXHIBIT 32.1 - IRONWOOD PHARMACEUTICALS INCa2197484zex-32_1.htm
EX-31.1 - EXHIBIT 31.1 - IRONWOOD PHARMACEUTICALS INCa2197484zex-31_1.htm
EX-31.2 - EXHIBIT 31.2 - IRONWOOD PHARMACEUTICALS INCa2197484zex-31_2.htm
EX-10.4.1 - EXHIBIT 10.4.1 - IRONWOOD PHARMACEUTICALS INCa2197484zex-10_41.htm
EX-10.14.1 - EXHIBIT 10.14.1 - IRONWOOD PHARMACEUTICALS INCa2197484zex-10_141.htm

QuickLinks -- Click here to rapidly navigate through this document


EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

        We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-165227, 333-165228, 333-165229, 333-165230, and 333-165231) of Ironwood Pharmaceuticals, Inc. of our report dated March 30, 2010, with respect to the consolidated financial statements of Ironwood Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2009.

  /s/ Ernst & Young LLP

Boston, Massachusetts

   

March 30, 2010

   



QuickLinks

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM